Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects.

📚 期刊: Eur Heart J Cardiovasc Pharmacother 📅 发表: 2026-01-01 🔬 PMID: 42033758 🔗 DOI: 10.1093/ehjcvp/pvag029 👁️ 浏览: 35

👤 作者: Van der Linden Lorenz, Vanassche Thomas

心血管

📑 引用格式

APA Vancouver 国标 GB/T 7714 BibTeX RIS

Van der Linden Lorenz, Vanassche Thomas (2026). Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects.. Eur Heart J Cardiovasc Pharmacother. https://doi.org/10.1093/ehjcvp/pvag029

🔗 分享文献

📝 阅读笔记

📄 相关文献

← 返回心血管查看原文 →

Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects.

📑 引用格式

🔗 分享文献

📝 阅读笔记

📄 相关文献

Proteomic insights into bi-atrial remodelling in persistent atrial fibrillation.

Single-session photon-counting CT protocol for simultaneous screening of coronar...

Clinical Documentation of an Individualized Emergency Action Plan for Young Athl...

Long-Term Outcomes of a Drug-Eluting Resorbable Scaffold vs Angioplasty in Infra...

Efficacy and safety of a novel size-adjustable cryoballoon versus conventional c...

Superior venous use of bridge balloon for percutaneous lead extraction in a pati...